The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...

This week’s Web3 Thoughts of the Week tackles DoorDash and stablecoins, spot Bitcoin ETFs, and DeFi’s tattered image.

Whatever the outcome of the Iran War, the Gulf states will lose their central position in the Middle East.

The study offers a valuable resource and integrates multiple complementary datasets to provide insights into regulatory mechanisms, although the conceptual advances are moderate and the central ...

Enterprise AI may have moved beyond the proof of concept phase, but many companies still seem stuck in the same place ...

Today, Striim announced new capabilities on Google Cloud that will enable enterprises to build and operate a new class of AI-driven systems powered by real-time, trusted data. The announcement ...

A single injection into the inner ear restored functional hearing in 90% of people born deaf because of mutations in the OTOF ...

ServiceNow’s earnings call painted a picture of a company executing well on growth, profitability and AI innovation, even as markets fret over deal timing and M&A optics. For investors, the core ...

The pharmaceutical revenue management function sits atop an enormous pool of value and an equally enormous pool of risk.

In a comprehensive analysis published by The National Interest, Dr. Marwa Maziad – an assistant professor of Israel Studies ...

Blackmagic Design today announced DaVinci Resolve 21, a significant update introducing the new Photo page, which enables ...